Fresenius Hid Cardiac Risks Of Dialysis Treatment, Suit Says

Law360, New York (February 11, 2013, 5:57 PM EST) -- A man who claims a dialysis treatment made by Fresenius Medical Care North America sent him into cardiac arrest sued the company in New Jersey on Friday, saying it deceived consumers and regulators as to the treatment’s safety.

Plaintiff William C. Jones claims that Fresenius concealed its knowledge of the defects and risks of Naturalyte liquid acid concentrate and Granuflo dry acid concentrate from patients, the medical community and the U.S. Food and Drug Administration, resulting in injuries to himself and other dialysis patients.

“These representations...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

JONES v. FRESENIUS MEDICAL CARE HOLDINGS, INC. et al


Case Number

1:13-cv-00820

Court

New Jersey

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

Joseph H. Rodriguez

Date Filed

February 7, 2013

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.